| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.083 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |